Sign up for our Newsletter:
COVID-19 Blog & Updates
It looks like much of the world is emerging from a summer of COVID and is now on the downward side of the epidemic curve.
Earlier this week, a formal internal advisory report from the US FDA said that the data did support boosters for the general population.
As of the middle of this week, new case rates are down in more than half of the United States and the overall rate is down approximately 5%.
Around the world, in most areas, the delta-driven increase in cases is driving an increase in vaccine acceptance.
The big news of the last week is that the first Covid vaccine from Pfizer and BioNTech has been fully approved in the United States.
The FDA authorized what is not a booster, but guidance that primary immunization for immunocompromised individuals should consist of 3 shots.
The major discussion this week is whether Delta is crowding out other variants so rapidly it will run out of susceptible hosts over a 6-8 week period.
COVID cases averaged across the United States have increased by about 50% with a 7-day average of about 27 cases per 100,000 per day.
The effects of the delta variant have changed both the public and governmental attitudes away from a sense of being nearly over this.
Subscribe to Our Newsletter